CMV prophylaxis: a useful step towards prevention of post-transplant diabetes?
Smith
R M
RM
Academic Renal Unit, University of Bristol, UK. Richard.Smith@bristol.ac.uk.
D016572:Cyclosporine / Q000009:adverse effects; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000209:etiology / Q000517:prevention & control / Q000821:virology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology*; D011183:Postoperative Complications / Q000517:prevention & control / Q000821:virology*; D016559:Tacrolimus / Q000009:adverse effects
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus